UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.92-101

2010

Volltextzugriff (PDF)

Adalimumab maintenance therapy for Crohn’s disease with intolerance or lost response to infliximab: an open‐label study

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.675-680

2007

Volltextzugriff (PDF)

Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (8), p.966-972

2008

Volltextzugriff (PDF)

Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (7), p.749-756

2009

Volltextzugriff (PDF)

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1175-1180

2012

Volltextzugriff (PDF)

Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1135-1144

2010

Volltextzugriff (PDF)

Infliximab for refractory ulcerative proctitis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (11), p.1178-1185

2010

Volltextzugriff (PDF)

Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3‐year single‐centre experience

Alimentary pharmacology & therapeutics, 2009-02, Vol.29 (4), p.416-423

2009

Volltextzugriff (PDF)

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

Gut, 2010-08, Vol.59 (8), p.1056-1065

2010

Volltextzugriff (PDF)

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.333-341

2003

Volltextzugriff (PDF)

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (8), p.984-993

2008

Volltextzugriff (PDF)

The role of acid suppression in patients with endoscopy‐negative reflux disease: the effect of treatment with esomeprazole or omeprazole

Alimentary pharmacology & therapeutics, 2004-08, Vol.20 (4), p.413-421

2004

Volltextzugriff (PDF)

Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

The New England journal of medicine, 1997-07, Vol.337 (4), p.237-240

1997

Volltextzugriff (PDF)

Easy clip to treat anal fistula tracts: a word of caution

International journal of colorectal disease, 2015-05, Vol.30 (5), p.621-624

2015

Volltextzugriff (PDF)

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (8), p.854-863

2009

Volltextzugriff (PDF)

Treatment of patients with heartburn without endoscopic evaluation: on‐demand treatment after effective continuous administration of lansoprazole 15 mg

Alimentary pharmacology & therapeutics, 2005-10, Vol.22 (7), p.635-643

2005

Volltextzugriff (PDF)

Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine

BMJ. British medical journal (International ed.), 1999-02, Vol.318 (7182), p.502

International edition, 1999

Volltextzugriff (PDF)

Certolizumab use in pregnancy

Gut, 2009-04, Vol.58 (4), p.608-608

2009

Volltextzugriff (PDF)

Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin

Gut, 1997-07, Vol.41 (1), p.87-92

1997

Volltextzugriff (PDF)

One‐week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

Alimentary pharmacology & therapeutics, 1998-04, Vol.12 (4), p.383-388

1998

Volltextzugriff (PDF)

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients

Cancer, 1994-07, Vol.74 (1), p.16-24

1994

Volltextzugriff (PDF)

Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications

International journal of radiation oncology, biology, physics, 1997-01, Vol.37 (2), p.313-324

1997

Volltextzugriff (PDF)

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Gut, 2011-07, Vol.60 (7), p.930-936

2011

Volltextzugriff (PDF)

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinoma

Journal of hepatology, 1996-03, Vol.24 (3), p.293-300

1996

Volltextzugriff (PDF)

Cobalamin deficiency with megaloblastic anaemia in one patient under long‐term omeprazole therapy

Journal of internal medicine, 1996-09, Vol.240 (3), p.161-164

1996

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(152)
Male
(86)
Middle Aged
(75)
Female
(73)
Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Adult
(69)
Gastroenterology & Hepatology
(48)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Aged
(44)
Gastroenterology. Liver. Pancreas. Abdomen
(27)
Treatment Outcome
(23)
Pharmacology. Drug Treatments
(22)
Digestive System
(19)
Other Diseases. Semiology
(19)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(18)
Adolescent
(17)
Double-Blind Method
(17)
Pharmacology & Pharmacy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Adalimumab maintenance therapy for Crohn’s disease with intolerance or lost response to infliximab: an open‐label study

Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience

Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease

Infliximab for refractory ulcerative proctitis

Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3‐year single‐centre experience

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

The role of acid suppression in patients with endoscopy‐negative reflux disease: the effect of treatment with esomeprazole or omeprazole

Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

Easy clip to treat anal fistula tracts: a word of caution

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Treatment of patients with heartburn without endoscopic evaluation: on‐demand treatment after effective continuous administration of lansoprazole 15 mg

Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine

Certolizumab use in pregnancy

Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin

One‐week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients

Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinoma

Cobalamin deficiency with megaloblastic anaemia in one patient under long‐term omeprazole therapy

Suchergebnisse filtern